Acacia Pharma Group plc
Financials data is not available for this stockFinancials details for this stock are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Acacia Pharma Group plc (ACPH.BR) Cash Flow Analysis
Acacia Pharma Group plc belongs to the Biotechnology segment of the Healthcare sector. Its stock is priced at 0.89, while its total market cap stands at N/A.
Cash Flow Overview
Acacia Pharma Group plc's cash flow assessment details how it manages money across operations, investments, and financing. This financial overview reflects the company's ability to fund activities, sustain growth, and respond to market conditions.
Key Cash Flow Metrics
Financial Position Indicators
Stock Performance Summary
See how Acacia Pharma Group plc has performed across short- and long-term periods.
Company Information
Investment Metrics
Understanding Cash Flow Statements
These statements detail the actual movement of money through a business, what comes in and what goes out. Cash flow reports exclude accruals, giving a cash-only perspective that income statements often don't provide.
Three Components of Cash Flow:
Operating Activities
Funds earned through main business functions
Investing Activities
Funds allocated to asset purchases, acquisitions, or market securities
Financing Activities
Money sourced through financing, equity sales, and dividends
Data Update: Financial data is updated regularly based on company filings.All financial metrics are trailing twelve months (TTM) unless otherwise specified. Currency: EUR. Exchange: EURONEXT.
Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please conduct your own research and consult with financial advisors before making investment decisions.
Acacia Pharma Group plc (ACPH.BR) Cash Flow Analysis
The cash flow statement reveals the Acacia Pharma Group plc (ACPH.BR) liquidity trends, with operating cash flow per share at $-0.56, reflecting core business performance. Investing activity changes were N/A, indicating capital expenditures or asset sales, while financing activity shifted by N/A, showing debt or equity movements. Free cash flow per share was $-0.56, highlighting funds available for growth or shareholder returns. Year-over-year change in operating cash flow is N/A, demonstrating financial health shifts. For deeper insights, compare these figures with income statements and balance sheets to assess sustainability and strategic priorities.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan